← Evidence library

BIB_362

FMT (Fecal Microbiota Transplant) + immunotherapy in melanoma — 2026 maturation; three Phase 2 trials Nat Med January 2026.

Evidence grade

A

Tier

1 (3 simultaneous Nat Med Phase 2 publications)

Cited by tasks

10, 17, 18, 19a

Identifiers

DOI:10.1038/s41591-025-04186-5

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_362/findings.md (research corpus). This page is a short context summary — not individualised medical advice.